- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07694778
Prevalence of Functional Dyspepsia in a Rural Community of Bangladesh : A Cross Sectional Study
5. juli 2026 opdateret af: Jabadur Rahman Peom, Bangladesh Medical University
Prevalence of Functional Dyspepsia in Rural Community of Bangladesh: A Cross Sectional Study
Functional dyspepsia (FD) is a common gastrointestinal disorder with an important impact on quality of life.
There is a paucity of updated data on the prevalence of FD in rural areas of Bangladesh.
The present study will be carried out to find the prevalence of FD in a community in rural Bangladesh.
It also assesses potential risk factors.
Eligible participants will first be evaluated for symptoms by a clinical interview using the standardized Rome IV functional dyspepsia questionnaire.
Those who meet Rome IV criteria will then have an upper gastrointestinal endoscopy to exclude underlying organic diseases to establish a definitive diagnosis.
Eventually patients with normal endoscopic findings will be diagnosed as having functional dyspepsia.
This allows the accurate calculation of disease prevalence.
Researchers will gather demographic information, lifestyle habits, and dietary patterns.
The results will give important baseline data on rural FD burdens.
Such data can inform community health care interventions.
Studieoversigt
Status
Rekruttering
Betingelser
Undersøgelsestype
Observationel
Tilmelding (Anslået)
730
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiekontakt
- Navn: Jabadur Rahman Peom
- Telefonnummer: +8801925311811
- E-mail: peom1994@gmail.com
Undersøgelse Kontakt Backup
- Navn: Samia Khanam Yeana
- Telefonnummer: +880 1671122573
- E-mail: khansamiayeana@gmail.com
Studiesteder
-
-
-
Dhaka, Bangladesh
- Rekruttering
- Bangladesh Medical University, Dhaka
-
Kontakt:
- Mohammad Asadur Rahman, MD
- Telefonnummer: +8801914239923
- E-mail: dr.asad74@gmail.com
-
Kontakt:
- Dewan Saifuddin Ahmed, FCPS, MD
- Telefonnummer: +8801711533495
- E-mail: saifgastro@gmail.com
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Ja
Prøveudtagningsmetode
Sandsynlighedsprøve
Studiebefolkning
Place of study: Shimulia Union, Ashulia, Savar, Dhaka, Bangladesh.
Study Population: All adults of two villages of Shimulia Union who will give their consent to participate in the study.
Beskrivelse
Inclusion Criteria:
- Age 18 years or above
- Resident of the selected community
Exclusion Criteria:
- Known diagnosis of organic GI diseases.(e.g., Peptic ulcer disease, Inflammatory Bowel Disease, celiac disease, Malignancy, Intestinal Tuberculosis)
- Severe cognitive impairment, or critical illness
- Individuals with a history of major abdominal surgery
- Pregnant women
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Prevalence of Functional Dyspepsia in a Rural Community of Bangladesh
Tidsramme: From January 2026 to December 2026
|
From January 2026 to December 2026
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Efterforskere
- Studieleder: Mohammad Asadur Rahman, Bangladesh Medical University
Publikationer og nyttige links
Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.
Generelle publikationer
- Kim YS, Kim N. Functional Dyspepsia: A Narrative Review With a Focus on Sex-Gender Differences. J Neurogastroenterol Motil. 2020 Jul 30;26(3):322-334. doi: 10.5056/jnm20026.
- Yamamoto Y, Furukawa S, Watanabe J, Kato A, Kusumoto K, Takeshita E, Ikeda Y, Yamamoto N, Kohara K, Saeki Y, Hiasa Y. Association Between Body Mass Index and Functional Dyspepsia in Young Japanese People. J Neurogastroenterol Motil. 2022 Apr 30;28(2):276-282. doi: 10.5056/jnm21076.
- Rahman MM, Ghoshal UC, Kibria MG, Sultana N, Yusuf MA, Nahar S, Ahmed F, Rowshon A, Hasan M. Functional Dyspepsia, Peptic Ulcer, and Helicobacter pylori Infection in a Rural Community of South Asia: An Endoscopy-Assisted Household Survey. Clin Transl Gastroenterol. 2021 Apr 16;12(4):e00334. doi: 10.14309/ctg.0000000000000334.
- Perveen I, Rahman MM, Saha M, Rahman MM, Hasan MQ. Prevalence of irritable bowel syndrome and functional dyspepsia, overlapping symptoms, and associated factors in a general population of Bangladesh. Indian J Gastroenterol. 2014 May;33(3):265-73. doi: 10.1007/s12664-014-0447-1. Epub 2014 Mar 26.
- Mounsey A, Barzin A, Rietz A. Functional Dyspepsia: Evaluation and Management. Am Fam Physician. 2020 Jan 15;101(2):84-88.
- Miwa H, Nagahara A, Asakawa A, Arai M, Oshima T, Kasugai K, Kamada K, Suzuki H, Tanaka F, Tominaga K, Futagami S, Hojo M, Mihara H, Higuchi K, Kusano M, Arisawa T, Kato M, Joh T, Mochida S, Enomoto N, Shimosegawa T, Koike K. Evidence-based clinical practice guidelines for functional dyspepsia 2021. J Gastroenterol. 2022 Feb;57(2):47-61. doi: 10.1007/s00535-021-01843-7. Epub 2022 Jan 21.
- Kovacs DB, Szekely A, Hubai AG, Palsson O. Prevalence, epidemiology and associated healthcare burden of Rome IV irritable bowel syndrome and functional dyspepsia in the adult population of Gibraltar. BMJ Open Gastroenterol. 2022 Aug;9(1):e000979. doi: 10.1136/bmjgast-2022-000979.
- Harer KN, Hasler WL. Functional Dyspepsia: A Review of the Symptoms, Evaluation, and Treatment Options. Gastroenterol Hepatol (N Y). 2020 Feb;16(2):66-74.
- Esterita T, Dewi S, Suryatenggara FG, Glenardi G. Association of Functional Dyspepsia with Depression and Anxiety: A Systematic Review. J Gastrointestin Liver Dis. 2021 Jun 18;30(2):259-266. doi: 10.15403/jgld-3325.
- Abdelazim O, Hassnine AA, Fathy B, Mgdy A, Semeda N, Mahmoud SR, Saad ZM, Mahmoud HA. The prevalence of functional dyspepsia using Rome IV questionnaire among chronic kidney disease patients. Ren Fail. 2024 Dec;46(1):2344651. doi: 10.1080/0886022X.2024.2344651. Epub 2024 Apr 24.
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
10. januar 2026
Primær færdiggørelse (Anslået)
1. december 2026
Studieafslutning (Anslået)
1. december 2026
Datoer for studieregistrering
Først indsendt
5. juli 2026
Først indsendt, der opfyldte QC-kriterier
5. juli 2026
Først opslået (Faktiske)
10. juli 2026
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
10. juli 2026
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
5. juli 2026
Sidst verificeret
1. juli 2026
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- 5877
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
UBESLUTET
IPD-planbeskrivelse
Because the study data includes sensitive personal health and clinical information for which participants did not grant broader sharing consent, individual-level data will not be publicly available.
To safeguard participant privacy and confidentiality, access to individual data is strictly confined to the primary study investigators.
Dissemination of findings through publications and presentations will rely solely on aggregate, unidentified data.
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .